Investor Centre

Summit is publicly-listed in the UK (LSE) and US (NASDAQ)

Regulatory News

Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019
VIEW NEWS
Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
VIEW NEWS

Share Price

LSE: SUMM
At 24/04/2019 02:33
NASDAQ: SMMT
At 24/04/2019 02:32